Variant report
Variant | nsv821268 |
---|---|
Chromosome Location | chr5:29854143-29855882 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr5:29854000-29854275 | Hela-S3 | cervix: | n/a | n/a |
2 | CEBPB | chr5:29853961-29854296 | HepG2 | liver: | n/a | chr5:29854144-29854155 |
3 | CEBPB | chr5:29853970-29854296 | ECC-1 | luminal epithelium: | n/a | chr5:29854144-29854155 |
4 | CEBPB | chr5:29853667-29854342 | Hela-S3 | cervix: | n/a | chr5:29854144-29854155 |
5 | CEBPB | chr5:29853931-29854345 | MCF-7 | breast: | n/a | chr5:29854144-29854155 |
6 | CEBPB | chr5:29854000-29854297 | A549 | lung: | n/a | chr5:29854144-29854155 |
7 | CEBPB | chr5:29853910-29854303 | MCF-7 | breast: | n/a | chr5:29854144-29854155 |
8 | EP300 | chr5:29853904-29854311 | MCF-7 | breast: | n/a | n/a |
9 | EP300 | chr5:29853670-29854325 | Hela-S3 | cervix: | n/a | n/a |
10 | FOS | chr5:29853814-29854274 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr5:29853783-29854198 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | GATA3 | chr5:29853775-29854337 | MCF-7 | breast: | n/a | n/a |
13 | GATA3 | chr5:29853762-29854393 | MCF-7 | breast: | n/a | n/a |
14 | GATA3 | chr5:29853742-29854320 | MCF-7 | breast: | n/a | n/a |
15 | GATA3 | chr5:29853685-29854434 | MCF-7 | breast: | n/a | n/a |
16 | HDAC2 | chr5:29853932-29854242 | MCF-7 | breast: | n/a | chr5:29853967-29853975 |
17 | MAFK | chr5:29854066-29854306 | Hela-S3 | cervix: | n/a | chr5:29854288-29854302 chr5:29854285-29854305 chr5:29854287-29854303 |
18 | POLR2A | chr5:29855399-29855400 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | RCOR1 | chr5:29853884-29854268 | Hela-S3 | cervix: | n/a | n/a |
20 | RFX5 | chr5:29853966-29854250 | Hela-S3 | cervix: | n/a | n/a |
21 | SIN3AK20 | chr5:29853731-29854382 | MCF-7 | breast: | n/a | n/a |
22 | STAT3 | chr5:29853816-29854295 | Hela-S3 | cervix: | n/a | chr5:29853868-29853879 |
23 | STAT3 | chr5:29854110-29854302 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | TCF7L2 | chr5:29853712-29854263 | Hela-S3 | cervix: | n/a | n/a |
25 | TEAD4 | chr5:29853891-29854291 | MCF-7 | breast: | n/a | n/a |
26 | ZNF217 | chr5:29853780-29854290 | MCF-7 | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29852340..29854743-chr5:29859491..29862426,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249744 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7724158 | chr5:29854154-29854155 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs565547022 | chr5:29854170-29854171 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs532647758 | chr5:29854176-29854177 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs7704413 | chr5:29854177-29854178 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs76821981 | chr5:29854191-29854192 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs367897011 | chr5:29854197-29854198 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs371695961 | chr5:29854204-29854205 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs11424263 | chr5:29854242-29854243 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs397755815 | chr5:29854251-29854252 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs536398965 | chr5:29854256-29854257 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs566425168 | chr5:29854262-29854263 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs548621070 | chr5:29854280-29854281 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs569963676 | chr5:29854282-29854283 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs186814727 | chr5:29854295-29854296 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs558656341 | chr5:29854306-29854307 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs192025310 | chr5:29854348-29854349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534904700 | chr5:29854355-29854356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553250877 | chr5:29854358-29854359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535395120 | chr5:29854382-29854383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs13172931 | chr5:29854388-29854389 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs13153010 | chr5:29854391-29854392 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29853800-29854400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:29853800-29854400 | Enhancers | Hela-S3 | cervix |